CPH •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/04/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeCPH
Market Capitalization1,259,300 mln
Float3,186 mln
Earnings Date08/05/2026
EPS
27.40
Exceptional
P / E
10.36
Fair value
1-Year Forecast
308
Modest upside
Relative Strength
15
/ 100
Significantly lagging
Debt / Equity
0.72
Moderate leverage
ROE
71.40
Exceptional
Business Description
Founded in 1923 and based in Denmark, Novo Nordisk is a global pharmaceutical company best known for its treatments targeting diabetes and obesity, as well as a range of rare conditions affecting blood, hormones, and growth. The company develops and sells medicines, smart insulin delivery devices, and digital dosing tools, serving patients across North America, Europe, Asia, Latin America, and beyond.
